PLASMA-LIPID PROFILE IN RATS WITH GENTAMICIN-INDUCED NEPHROTOXICITY

被引:21
作者
ABDELGAYOUM, AA
ALI, BH
GHAWARSHA, K
BASHIR, AA
机构
[1] AL ARAB MED UNIV,FAC MED,DEPT BIOCHEM,BENGHAZI,LIBYA
[2] AL ARAB MED UNIV,FAC MED,DEPT PHARMACOL,BENGHAZI,LIBYA
来源
HUMAN & EXPERIMENTAL TOXICOLOGY | 1993年 / 12卷 / 05期
关键词
D O I
10.1177/096032719301200505
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
1 Administration of gentamicin to rats at doses of 20, 40 or 80 mg kg-1 d-1 for 6 days induced nephrotoxicity exhibited by elevated plasma creatinine concentration and a decrease in alkaline phosphatase activity in rat kidney cortex. 2 Gentamicin treatment produced significant elevation in plasma total cholesterol amounting to 70% at the 80 mg kg-1 dose. At this dose, the combined cholesterol fractions of low density and very low density lipoproteins increased by more than two-fold. 3 Gentamicin treatment also caused significant increase in plasma triglyceride concentration, while plasma phospholipid levels showed dose-dependent reductions. 4 In another experiment recovery of the aforementioned parameters was assessed 7 and 14 days after the withdrawal of gentamicin, administered at a dose of 40 mg kg-1 d-1 for 6 days. After 7 days from drug discontinuation, both plasma creatinine and total cholesterol concentrations returned to the control levels, while triglyceride concentration was still significantly higher than control 14 days after stoppage of treatment, 5 Plasma phospholipid concentration and the activity of cortical alkaline phosphatase were still significantly lower than control 14 days after cessation of the treatment.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 21 条
[1]  
ARNOFF GR, 1983, CHEMOTHERAPY, V23, P74
[2]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[3]   REVISED ASSAY FOR SERUM PHENYL PHOSPHATASE-ACTIVITY USING 4-AMINO-ANTIPYRINE [J].
BELFIELD, A ;
GOLDBERG, DM .
ENZYME, 1971, 12 (05) :561-&
[4]   REDUCTION OF EXPERIMENTAL GENTAMICIN-NEPHROTOXICITY IN RATS BY DIETARY CALCIUM LOADING [J].
BENNETT, WM ;
ELLIOTT, WC ;
HOUGHTON, DC ;
GILBERT, DN ;
DEFEHR, J ;
MCCARRON, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (03) :508-512
[5]   SECRETION OF LIPOPROTEINS, APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-E BY ISOLATED AND PERFUSED LIVER OF RAT WITH EXPERIMENTAL NEPHROTIC SYNDROME [J].
CALANDRA, S ;
GHERARDI, E ;
FAINARU, M ;
GUAITANI, A ;
BARTOSEK, I .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 665 (02) :331-338
[6]   POST-HEPARIN HEPATIC AND LIPOPROTEIN-LIPASE ACTIVITIES IN NEPHROTIC SYNDROME [J].
CHAN, MK ;
PERSAUD, JW ;
VARGHESE, Z ;
MOORHEAD, JF .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1984, 14 (06) :841-847
[7]   LOVASTATIN IN THE TREATMENT OF MULTIFACTORIAL HYPERLIPIDEMIA ASSOCIATED WITH PROTEINURIA [J].
GOLPER, TA ;
ILLINGWORTH, DR ;
MORRIS, CD ;
BENNETT, WM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 13 (04) :312-320
[8]   GLOMERULAR SCLEROTIC LESIONS IN THE RAT - HISTOCHEMICAL ANALYSIS OF THEIR MACROMOLECULAR AND CELLULAR COMPOSITION [J].
GROND, J ;
VANGOOR, H ;
ERKELENS, DW ;
ELEMA, JD .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1986, 51 (06) :521-534
[9]   TREATMENT OF HYPERLIPIDEMIA WITH PROBUCOL REDUCES PROTEINURIA IN PUROMYCIN AMINONUCLEOSIDE-INDUCED NEPHROTIC RATS [J].
HIRANO, T ;
MAMO, JCL ;
OHNAMI, K ;
SUGISAKI, T .
NEPHRON, 1990, 54 (04) :358-359
[10]   TREATMENT OF HYPERLIPIDEMIA WITH PROBUCOL SUPPRESSES THE DEVELOPMENT OF FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS IN CHRONIC AMINONUCLEOSIDE NEPHROSIS [J].
HIRANO, T ;
MOROHOSHI, T .
NEPHRON, 1992, 60 (04) :443-447